Stay informed, stay ahead.
California health officials are investigating a possible local spread of a rare and more serious strain of mpox known as clade I, after identifying two cases in Los Angeles and Long Beach with no recent travel history. Until now, this strain had only appeared in the U.S. among travelers returning from Africa. Its appearance here…
Novartis said its cancer drug Pluvicto has reduced the risk of disease progression or death by 28% in men with an advanced form of prostate cancer. The findings come from a large Phase III clinical trial. The study focused on men with PSMA-positive metastatic hormone-sensitive prostate cancer. These patients received Pluvicto along with standard hormone-based…
Your toothbrush is home to millions of microbes. Scientists say 1–12 million bacteria, fungi and viruses can live between the bristles at any time. Most come from your own mouth — swept up along with saliva, food traces and skin cells each time you brush. But not all of them are friendly. Researchers have found…
Scientists at the University of Surrey have developed a heat-sensitive label that changes colour when vaccines are exposed to temperatures that are too high — a common reason doses are thrown away around the world. The label attaches directly to the vials and gives a visible warning if the vaccine cold chain has been broken….
Namibia’s Ministry of Health has declared an mpox outbreak in the coastal city of Swakopmund, prompting an immediate public-health response. In an official statement, the ministry confirmed that surveillance teams, contact tracers and rapid responders are already on the ground to contain the spread. Authorities say early detection and strict monitoring are critical at this…
Trodelvy, developed by Gilead Sciences, has delivered promising results in a late-stage trial for advanced triple-negative breast cancer (TNBC). Researchers found that the drug lowered the risk of disease progression by 38% compared to standard chemotherapy. The study enrolled 558 patients with TNBC whose tumours did not express PD-L1. Participants receiving Trodelvy reached a median…
AstraZeneca and Daiichi Sankyo have announced that their new drug Datroway significantly improved survival in patients with aggressive triple-negative breast cancer (TNBC). The results were revealed at the European Society for Medical Oncology (ESMO) Congress in Berlin. In the trial, patients receiving Datroway achieved a median overall survival of 23.7 months versus 18.7 months for those treated with standard chemotherapy….
In Atlanta, thousands of doctors, researchers and medical students have gathered for IDWeek 2025, the annual conference on infectious diseases, running from October 19-22. The event takes place at the Georgia World Congress Center. This year’s conference centers on three major themes: public-health strategy, artificial-intelligence tools in healthcare and preparedness for future disease outbreaks. Leading…
For the first time, people in England and Wales will be able to receive a long-acting injection to prevent HIV on the NHS, bringing the policy in line with Scotland. The jab — cabotegravir (CAB-LA) — is taken every two months and offers an alternative to daily PrEP tablets. Health officials hope the rollout will…
The World Health Organization (WHO) has revealed the theme for the 2025 World No Tobacco Day: “Unmasking the Appeal: Exposing Industry Tactics on Tobacco and Nicotine Products.” The campaign aims to show how the tobacco and nicotine industries use sweet flavours, bright packaging and social-media hype to attract young people. These tactics make harmful products look fun or…
